Gemina Laboratories Ltd.
GLABF
$0.528
-$0.0839-13.71%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 500.00 | 29.90K | 149.70K | 1.20K | 700.00 |
| Total Receivables | 24.00K | 10.30K | 23.60K | 28.50K | 28.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 49.10K | 79.80K | 100.30K | 44.30K | 39.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 73.60K | 119.90K | 273.60K | 74.00K | 69.30K |
|
|
|||||
| Total Current Assets | 73.60K | 119.90K | 273.60K | 74.00K | 69.30K |
| Net Property, Plant & Equipment | 217.50K | 248.20K | 90.80K | 249.10K | 276.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 993.70K | 1.10M | 1.08M | 1.05M | 1.09M |
|
|
|||||
| Total Accounts Payable | 1.97M | 1.80M | 1.61M | 1.40M | 1.25M |
| Total Accrued Expenses | 1.20M | 732.40K | 532.50K | 350.10K | 664.90K |
| Short-term Debt | 690.20K | 831.70K | 808.30K | 728.10K | 149.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 68.80K | 69.50K | 25.10K | 58.70K | 59.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.94M | 3.44M | 2.98M | 2.53M | 2.12M |
|
|
|||||
| Total Current Liabilities | 3.94M | 3.44M | 2.98M | 2.53M | 2.12M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 690.20K | 831.70K | 808.30K | 728.10K | 149.50K |
| Capital Leases | 121.10K | 144.30K | 26.40K | 134.70K | 154.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.06M | 3.58M | 3.01M | 2.67M | 2.27M |
|
|
|||||
| Common Stock & APIC | 8.28M | 8.67M | 8.72M | 8.18M | 8.40M |
| Retained Earnings | -14.40M | -13.93M | -13.44M | -12.80M | -12.53M |
| Treasury Stock & Other | 3.05M | 2.78M | 2.79M | 3.00M | 2.94M |
| Total Common Equity | -3.06M | -2.48M | -1.92M | -1.62M | -1.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.06M | -2.48M | -1.92M | -1.62M | -1.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.06M | -2.48M | -1.92M | -1.62M | -1.18M |
|
|
|||||